Under the Paperwork Reduction Act of 1995 no persons are required to respond to a collection of information unless it displays a valid OMB control number.
PTO Form 1581 (Rev 09/2005) |
OMB No. 0651-0054 (Exp 12/31/2020) |
Request for Extension of Time to File a Statement of Use
(15 U.S.C. Section 1051(d))
The table below presents the data as entered.
Input Field
|
Entered
|
SERIAL NUMBER |
88221046 |
LAW OFFICE ASSIGNED |
LAW OFFICE 121 |
MARK SECTION |
MARK |
http://uspto.report/TM/88221046/mark.png (stylized and/or with design) |
STANDARD CHARACTERS |
NO |
USPTO-GENERATED IMAGE |
NO |
OWNER SECTION (current) |
NAME |
Clearside Biomedical, Inc. |
MAILING ADDRESS |
900 North Point Parkway, Suite 200 |
CITY |
Alpharetta |
STATE |
Georgia |
ZIP/POSTAL CODE |
30005 |
STATE/COUNTRY/REGION/JURISDICTION/U.S. TERRITORY |
United States |
OWNER SECTION (proposed) |
NAME |
Clearside Biomedical, Inc. |
MAILING ADDRESS |
900 North Point Parkway, Suite 200 |
CITY |
Alpharetta |
STATE |
Georgia |
ZIP/POSTAL CODE |
30005 |
STATE/COUNTRY/REGION/JURISDICTION/U.S. TERRITORY |
United States |
EMAIL |
XXXX |
CORRESPONDENCE INFORMATION (current) |
NAME |
BASSAM N. IBRAHIM |
PRIMARY EMAIL ADDRESS FOR CORRESPONDENCE |
bassam.ibrahim@bipc.com |
SECONDARY EMAIL ADDRESS(ES) (COURTESY COPIES) |
NOT PROVIDED |
DOCKET/REFERENCE NUMBER |
0080003-115 |
CORRESPONDENCE INFORMATION (proposed) |
NAME |
Bassam N. Ibrahim |
PRIMARY EMAIL ADDRESS FOR CORRESPONDENCE |
bassam.ibrahim@bipc.com |
SECONDARY EMAIL ADDRESS(ES) (COURTESY COPIES) |
kathy.bazil@bipc.com |
DOCKET/REFERENCE NUMBER |
0080003-115 |
GOODS AND/OR SERVICES SECTION |
INTERNATIONAL CLASS |
005 |
CURRENT IDENTIFICATION |
Ocular pharmaceuticals; Ophthalmic preparations |
GOODS OR SERVICES |
KEEP ALL LISTED |
INTERNATIONAL CLASS |
010 |
CURRENT IDENTIFICATION |
Medical devices, namely, a needle-based injection system for delivery of pharmaceuticals and injection needles; Ophthalmic medical devices,
namely, a needle-based injection system for delivery of pharmaceuticals to eye tissue and injection needles; drug delivery systems |
GOODS OR SERVICES |
KEEP ALL LISTED |
EXTENSION SECTION |
EXTENSION NUMBER |
2 |
ONGOING EFFORT |
product or service research or development |
ALLOWANCE MAIL DATE |
06/11/2019 |
STATEMENT OF USE |
NO |
PAYMENT SECTION |
NUMBER OF CLASSES |
2 |
SUBTOTAL AMOUNT [EXTENSION FEE] |
250 |
TOTAL AMOUNT |
250 |
SIGNATURE SECTION |
ORIGINAL PDF FILE |
hw_1992474448-121053832_.
_416_-_XIPERE__Stylied__- _Signed_Dec_Second_Extens ion_of_Time.pdf |
CONVERTED PDF FILE(S)
(2 pages) |
\\TICRS\EXPORT18\IMAGEOUT 18\882\210\88221046\xml1\ ESU0002.JPG |
|
\\TICRS\EXPORT18\IMAGEOUT 18\882\210\88221046\xml1\ ESU0003.JPG |
SIGNATORY'S NAME |
Leslie Zacks |
SIGNATORY'S POSITION |
General Counsel |
FILING INFORMATION |
SUBMIT DATE |
Fri Apr 24 12:16:47 ET 2020 |
TEAS STAMP |
USPTO/ESU-XXX.XXX.XX.XX-2
0200424121647991752-88221
046-710ea3c7cd7dc19d2c677
2af8ef653e1c71c578410d23c
42469fb47a9aeb4acb-CC-164
63111-2020042412105383201
5 |
Under the Paperwork Reduction Act of 1995 no persons are required to respond to a collection of information unless it displays a valid OMB control number.
PTO Form 1581 (Rev 09/2005) |
OMB No. 0651-0054 (Exp 12/31/2020) |
SOU Extension Request
(15 U.S.C. Section 1051(d))
To the Commissioner for Trademarks:
MARK: XIPERE (stylized and/or with design, see http://uspto.report/TM/88221046/mark.png)
SERIAL NUMBER: 88221046
OWNER AND/OR ENTITY INFORMATION
The owner proposes to amend the following:
Current: Clearside Biomedical, Inc., having an address of
900 North Point Parkway, Suite 200
Alpharetta, Georgia 30005
United States
Proposed: Clearside Biomedical, Inc., having an address of
900 North Point Parkway, Suite 200
Alpharetta, Georgia 30005
United States
Phone:
Fax:
Email: XXXX
The owner requests a six-month extension of time to file the Statement of Use under 37 C.F.R. Section 2.89 in this application. The Notice of Allowance mailing date was 06/11/2019.
For International Class 005:
Current identification: Ocular pharmaceuticals; Ophthalmic preparations
For a trademark/service mark: The applicant has a continued bona fide intention, and is entitled, to use the mark in commerce on or in connection with all of the goods/services listed in the Notice
of Allowance or as subsequently modified for this specific class; for a collective/certification mark: the applicant has a continued bona fide intention, and is entitled, to exercise legitimate
control over the use of the mark in commerce on or in connection with the goods/services/collective membership organization listed in the Notice of Allowance, or as subsequently modified for this
specific class.
For International Class 010:
Current identification: Medical devices, namely, a needle-based injection system for delivery of pharmaceuticals and injection needles; Ophthalmic medical devices, namely, a needle-based injection
system for delivery of pharmaceuticals to eye tissue and injection needles; drug delivery systems
For a trademark/service mark: The applicant has a continued bona fide intention, and is entitled, to use the mark in commerce on or in connection with all of the goods/services listed in the Notice
of Allowance or as subsequently modified for this specific class; for a collective/certification mark: the applicant has a continued bona fide intention, and is entitled, to exercise legitimate
control over the use of the mark in commerce on or in connection with the goods/services/collective membership organization listed in the Notice of Allowance, or as subsequently modified for this
specific class.
This is the second extension request. The applicant has made the following ongoing efforts to use the mark in commerce on or in connection with each of those goods/services covered by the extension
request: product or service research or development
Correspondence Information (current):
BASSAM N. IBRAHIM
PRIMARY EMAIL FOR CORRESPONDENCE: bassam.ibrahim@bipc.com
SECONDARY EMAIL ADDRESS(ES) (COURTESY COPIES): NOT PROVIDED
Correspondence Information (proposed):
Bassam N. Ibrahim
PRIMARY EMAIL FOR CORRESPONDENCE: bassam.ibrahim@bipc.com
SECONDARY EMAIL ADDRESS(ES) (COURTESY COPIES): kathy.bazil@bipc.com
Requirement for Email and Electronic Filing: I understand that a valid email address must be maintained by the owner/holder and the owner's/holder's attorney, if appointed, and that all
official trademark correspondence must be submitted via the Trademark Electronic Application System (TEAS).
A fee payment in the amount of $250 will be submitted with the form, representing payment for 2 classes.
Declaration
Original PDF file:
hw_1992474448-121053832_.
_416_-_XIPERE__Stylied__- _Signed_Dec_Second_Extens ion_of_Time.pdf
Converted PDF file(s) (2 pages)
Signature File1
Signature File2
Signatory's Name: Leslie Zacks
Signatory's Position: General Counsel
RAM Sale Number: 88221046
RAM Accounting Date: 04/24/2020
Serial Number: 88221046
Internet Transmission Date: Fri Apr 24 12:16:47 ET 2020
TEAS Stamp: USPTO/ESU-XXX.XXX.XX.XX-2020042412164799
1752-88221046-710ea3c7cd7dc19d2c6772af8e
f653e1c71c578410d23c42469fb47a9aeb4acb-C
C-16463111-20200424121053832015